Skip to main content
Premium Trial:

Request an Annual Quote

GNF to Use Ingenuity Pathways Analysis Technology

NEW YORK, Nov. 24 (GenomeWeb News) - Ingenuity Systems said today that its Pathways Analysis application has been licensed for research use by the Genomics Institute of the Novartis Research Foundation.


The Pathways Analysis system maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.


Terms of the deal were not disclosed.


Ingenuity has recently licensed the Pathways Analysis system to the Stanford Genome Technology Center and GlaxoSmithKline, and recently signed a software distribution deal with investor Affymetrix.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.